Skip to main content
Clinical Trials/JPRN-jRCT1092220091
JPRN-jRCT1092220091
Completed
未知

Clinical trial to evaluate the efficacy and safety of nDM-14R intended for two-stage operation cases.

Kawasumi. laboratory .inc0 sites130 target enrollmentJuly 2, 2012

Overview

Phase
未知
Intervention
Not specified
Conditions
Postoperative Adhesion
Sponsor
Kawasumi. laboratory .inc
Enrollment
130
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 2, 2012
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Kawasumi. laboratory .inc

Eligibility Criteria

Inclusion Criteria

  • (1\) Patients of 20 years or more at the time of obtaining informed consent.
  • (2\) Patient who will have covering colostomy and colostomy closure.
  • (3\) Patient or legal representative who well understand the protocol with written informed consent.

Exclusion Criteria

  • (1\) Patient scheduled for first\-stage laparoscopic surgery.
  • (2\) Patient who need intraperitoneal injection of perfusate of drugs that affect on adhesion formation during 24 hours to 7 days after first\-stage surgery.
  • (3\) Patient who have had previous abdominal median incision.
  • (4\) Cancer patient of stageIV.
  • (5\) Patient with ECOG Performance Status over 3\.
  • (6\) Patient with a history of severe drug allergy.
  • (7\) Patient with an allergy to materials of investigational device.
  • (8\) Patient with body\-wide infection.
  • (9\) Patient who wish to become pregnant during the study or pregnant, lactating.
  • (10\) Patient from the course of the disease, life expectancy less than one year.

Outcomes

Primary Outcomes

Not specified

Similar Trials